The Pezcoller Foundation-EACR Translational Cancer Researcher Award celebrates academic excellence and achievements in the field of translational cancer research. The award is presented annually to a researcher of excellence with no more than 15 years post-doctoral experience (or equivalent degree), with at least five years spent in Europe and presently employed in a European institution.
The winner gives the prestigious Pezcoller Foundation-EACR Translational Cancer Researcher Award Lecture at the EACR Congress. The next award will be presented at the EACR 2021 Congress to be held from 09-12 June 2021. As an invited speaker the award winner will receive a free registration, plus accommodation and travel costs.
The award winner will receive a €10,000 honorarium. They will also be invited to give a lecture in Trento, Italy, at a date to be agreed, for which they will receive accommodation and travel costs.
We invite the nomination of cancer researchers who have demonstrated academic excellence and achievements in the field of translational cancer research. Translational research is defined as a fundamental research discovery that has been taken through pre-clinical and clinical development to human proof-of-concept studies. Self-nominations cannot be accepted.
Nominees must meet the following criteria. The nominee should:
How to submit your nomination:
Please email your completed nomination form and accompanying documents as a single pdf to firstname.lastname@example.org
Deadline for receipt of nominations: 11 January 2021
The EACR is grateful for the continued support of its Industry Partners: